ClinicalTrials.Veeva

Menu

Impact of Bariatric Surgery on Heart Disease Compared to Standard Care (MIMS)

D

Danderyd Hospital

Status

Not yet enrolling

Conditions

Bariatric Surgery Candidate
Heart Diseases
Obesity, Morbid

Treatments

Procedure: Bariatric surgery
Procedure: Standard care

Study type

Interventional

Funder types

Other

Identifiers

NCT06346145
MIMS study
2023-00453 (Other Grant/Funding Number)

Details and patient eligibility

About

Obesity is associated with type 2 diabetes (T2D) and cardiovascular disease (CVD). Metabolic and bariatric surgery (MBS) has in several randomized controlled trials (RCT) been shown to be superior to best medical therapy in the treatment of T2D. In the area of CVD, RCT after MBS are lacking. It was recently demonstrated in a cohort study that MBS in patients with severe obesity and a previous myocardial infarction (MI) was associated with a 50% reduction in the risk of death and new MI. The aim of this proposal is to confirm this in a nationwide RCT. Using the nationwide SWEDEHEART database patients with severe obesity and a previous MI will be identified. They will be contacted and offered participation. After informed consent the patients will be randomized to MBS or optimized care (including visit with a cardiologist and optimization of secondary preventive measures and referral to dietician/physiotherapist). The primary outcome measure is a major cardiovascular adverse event (MACE). Secondary outcome measures include mortality, new MI, stroke, heart failure and atrial fibrillation. Tertiary outcome measures include health related quality of life and surgical complications. Patients will be followed in the nationwide metabolic surgery register SOReg, the national inpatient register, national cause of death register, the Swedish prescribed drug register, and the Swedish population register. If positive results these can be included in guidelines for MBS.

Enrollment

500 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • MI (as defined by the universal definition of MI) at least 1 year before inclusion.
  • BMI ≥35 kg/m2
  • Written informed consent obtained

Exclusion criteria

  • Any condition that may influence the patient's ability to comply with study protocol.
  • Earlier MBS or operation for gastric or duodenal ulcer or reflux disease
  • Other condition that makes patient not suitable for MBS according to responsible surgeon and anesthesiologist
  • Unable to understand Swedish.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

500 participants in 2 patient groups

Bariatric surgery
Active Comparator group
Description:
Gastric bypass or gastric sleeve
Treatment:
Procedure: Bariatric surgery
Standard care
Active Comparator group
Description:
Standard obesity treatment offered in Swedish regions
Treatment:
Procedure: Standard care

Trial contacts and locations

0

Loading...

Central trial contact

Erik Näslund, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems